Zobrazeno 1 - 10
of 19
pro vyhledávání: '"Alejandro Orrico-Sanchéz"'
Autor:
Salvador Domènech-Montoliu, Joan Puig-Barberà, María Rosario Pac-Sa, Alejandro Orrico-Sanchéz, Lorna Gómez-Lanas, Diego Sala-Trull, Carmen Domènech-Leon, Alba Del Rio-González, Manuel Sánchez-Urbano, Paloma Satorres-Martinez, Laura Aparisi-Esteve, Gema Badenes-Marques, Roser Blasco-Gari, Juan Casanova-Suarez, María Gil-Fortuño, Noelia Hernández-Pérez, David Jovani-Sales, Laura López-Diago, Cristina Notari-Rodríguez, Oscar Pérez-Olaso, María Angeles Romeu-Garcia, Raquel Ruíz-Puig, Alberto Arnedo-Pena
Publikováno v:
Epidemiologia, Vol 5, Iss 2, Pp 167-186 (2024)
Our goal was to determine the cellular immune response (CIR) in a sample of the Borriana COVID-19 cohort (Spain) to identify associated factors and their relationship with infection, reinfection and sequelae. We conducted a nested case–control stud
Externí odkaz:
https://doaj.org/article/ad842c9cbc1e4836a8b3c3c01ff3c6fc
Autor:
Salvador Domènech-Montoliu, Joan Puig-Barberà, Olga Guerra-Murcia, María Rosario Pac-Sa, Alejandro Orrico-Sanchéz, Lorna Gómez-Lanas, Diego Sala-Trull, Carmen Domènech-Leon, Alba Del Rio-González, Manuel Sánchez-Urbano, Paloma Satorres-Martinez, Marta Latorre-Poveda, Sara Ferrando-Rubert, Laura Aparisi-Esteve, Gema Badenes-Marques, Roser Blasco-Gari, Juan Casanova-Suarez, María Fontal-Carcel, María Gil-Fortuño, Noelia Hernández-Pérez, David Jovani-Sales, Laura López-Diago, Cristina Notari-Rodríguez, Oscar Pérez-Olaso, María Angeles Romeu-Garcia, Raquel Ruíz-Puig, Alberto Arnedo-Pena
Publikováno v:
Epidemiologia, Vol 4, Iss 1, Pp 63-73 (2023)
Our objective was to estimate the incidence of COVID-19 and the ABO blood Groups in the mass-gathering events (MGEs) during the Falles Festival in Borriana (Spain) from 6–10 March 2020. We conducted a population-based retrospective cohort study and
Externí odkaz:
https://doaj.org/article/278f303a9bac41b6b927aa4be07e3d09
Autor:
Mónica López-Lacort, Ana Corberán-Vallet, Francisco J. Santonja, Cintia Muñoz-Quiles, Javier Díez-Domingo, Alejandro Orrico-Sánchez
Publikováno v:
Journal of Infection and Public Health, Vol 17, Iss 8, Pp 102492- (2024)
Background: A new monoclonal antibody (nirsevimab; Beyfortus®) and a bivalent prefusion RSV vaccine (Abrysvo®) for maternal immunization have been approved recently. This is a modelling study to estimate the potential impact of different immunizati
Externí odkaz:
https://doaj.org/article/ede641055b5549a480ff8733070d2061
Autor:
Elisa Correcher-Martínez, Mónica López-Lacort, Cintia Muñoz-Quiles, Javier Díez-Domingo, Alejandro Orrico-Sánchez
Publikováno v:
International Journal of Infectious Diseases, Vol 143, Iss , Pp 107037- (2024)
Objectives: We aimed to compare the risk of herpes zoster (HZ) in adults with and without laboratory-confirmed severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. Methods: This retrospective dynamic cohort study analyzed data from
Externí odkaz:
https://doaj.org/article/5ccebbac1f2342bea2af4083254a13f7
Autor:
Jorge Mestre-Ferrándiz, Agustín Rivero, Alejandro Orrico-Sánchez, Álvaro Hidalgo, Fernando Abdalla, Isabel Martín, Javier Álvarez, Manuel García-Cenoz, Maria del Carmen Pacheco, María Garcés-Sánchez, Néboa Zozaya, Raúl Ortiz-de-Lejarazu
Publikováno v:
BMC Infectious Diseases, Vol 24, Iss 1, Pp 1-14 (2024)
Abstract Background Respiratory syncytial virus (RSV) is a highly infectious disease that poses a significant clinical and medical burden, as well as social disruption and economic costs, recognized by the World Health Organization as a public health
Externí odkaz:
https://doaj.org/article/a3ba925ab45b491f94d032959b3ccef0
Autor:
Alejandro Orrico-Sanchez, Bruno P. Guiard, Stella Manta, Jacques Callebert, Jean-Marie Launay, Franck Louis, Antoine Paccard, Carole Gruszczynski, Catalina Betancur, Vincent Vialou, Sophie Gautron
Publikováno v:
Translational Psychiatry, Vol 13, Iss 1, Pp 1-12 (2023)
Abstract Selective serotonin reuptake inhibitors (SSRI) are common first-line treatments for major depression. However, a significant number of depressed patients do not respond adequately to these pharmacological treatments. In the present preclinic
Externí odkaz:
https://doaj.org/article/d94a2324bd604020be6ec223f77ddc2a
Autor:
Soledad Munoz‑Ramirez, Begona Escribano‑Lopez, Vallivana Rodrigo‑Casares, Carlos Vergara‑Hernandez, Desamparados Gil‑Mary, Ignacio Sorribes‑Monrabal, Maria Garces‑Sanchez, Maria‑Jesus Munoz‑Del‑Barrio, Ana‑Maria Albors‑Fernandez, Maria‑Isabel Ubeda‑Sansano, Maria‑Victoria Planelles‑Cantarino, Ester‑Maria Largo‑blanco, Eva Suarez‑Vicent, Javier Garcia‑Rubio, Patricia Bruijning‑Verhagen, Alejandro Orrico‑Sanchez, Javier Diez‑Domingo
Publikováno v:
BMC Medical Research Methodology, Vol 24, Iss 1, Pp 1-1 (2024)
Externí odkaz:
https://doaj.org/article/233447669307450994f70bd74918bc8b
Autor:
Juan Juaneda, Pablo Estrella-Porter, Carolina Blanco-Calvo, Alejandro Orrico-Sánchez, José Antonio Lluch-Rodrigo, Eliseo Pastor-Villalba
Publikováno v:
Vaccines, Vol 12, Iss 6, p 623 (2024)
Public funding of vaccines may enhance vaccination rates, co-administration, and timeliness. The impacts of including the serogroup B meningococcus vaccine (MenB) into the national immunisation schedule on vaccination rates, co-administration rates,
Externí odkaz:
https://doaj.org/article/3f1336d40df44670b863aff481003d0b
Autor:
Anke L. Stuurman, Antonio Carmona, Jorne Biccler, Alexandre Descamps, Miriam Levi, Ulrike Baum, Ainara Mira-Iglesias, Stefania Bellino, Uy Hoang, Simon de Lusignan, Roberto Bonaiuti, Bruno Lina, Caterina Rizzo, Hanna Nohynek, Javier Díez-Domingo, DRIVE Study Contributors, Anca Cristina Drăgănescu, Oana Săndulescu, Daniela Piţigoi, Victor Daniel Miron, Anca Streinu-Cercel, Anuţa Bilaşco, Adrian Streinu-Cercel, Dragoş Florea, Ovidiu Vlaicu, Simona Paraschiv, Leontina Bănică, Dan Oţelea, Monika Redlberger-Fritz, Eva Geringer, Amparo López-Bernus, Ana Haro Perez, Nieves Gutierrez Zufiaurre, Cristina Carbonell Muñoz, Miguel Marcos Martin, Muñoz Juan Luis Bellido, Isabel Gil Rodríguez, Antonio Muro Alvarez, Moncef Belhassen Garcia, Giancarlo Icardi, Stefano Mosca, Donatella Panatto, Emanuele Montomoli, Silvana Castaldi, Andrea Orsi, Alexander Domnich, Maria Chironna, Daniela Loconsole, Ilaria Manini, Christian Napoli, Alessandra Torsello, Elena Pariani, and Piero Luigi Lai, Susana Otero-Romero, Andrés Antón Pagarolas, Cristina Andrés, Ingrid Carbonés, Oleguer Pares, Mar Fornaguera, Anna Oller, Xavier Salgado, Patricia Tejerina, Cristina Martinez, Alejandro Orrico-Sánchez, F. Xavier López-Labrador, Beatriz Mengual-Chuliá, Judit Sánchez Soler, María Jinglei Casanova Palomino, Juan Mollar-Maseres, Miguel Tortajada-Girbés, Noelia Rodríguez-Blanco, Mario Carballido-Fernández, Raquel Andreu Ivorra, Àngels Sierra Fortuny, Beatriz Segura Segura, Cristina Mingot Ureta, Sagrario Corrales Díaz-Flores, Ángela Sánchez Pla, María Dolores Tirado Balaguer, Juan Alberola, José Miguel Nogueira, Juan J Camarena, Francisco Arjona-Zaragozí, Maruan Shalabi Benavent, José Luis López-Hontangas, María Dolores Gómez, Alejandro Martín-Quirós, Carlos Cañada Illana, Emilio Cendejas, Irma Casas García, Guillermo Mena Pinilla, María Esteve Pardo, Lola Álamo Junquera, Cristina Casañ, Sandra Fernandez Morodo, Agueda Hernández, Pere-Joan Cardona, Marta Segura, Andreu C. Pelegrin, Sara González-Gómez, Verónica Saludes, Elisa Martró, Valtýr Stefánsson Thors, Kristín L. Björnsdóttir, Liem Luong, Zineb Lesieur, Yacine Saidi, Rebecca Bauer, Christine Pereira, Philippe Vanhems, Fabrice Lainé, Florence Galtier, Xavier Duval, Christine Durier, Paolo Bonanni, Alfredo Vannacci, Claudia Ravaldi
Publikováno v:
Frontiers in Public Health, Vol 11 (2023)
IntroductionDevelopment of Robust and Innovative Vaccine Effectiveness (DRIVE) was a European public–private partnership (PPP) that aimed to provide annual, brand-specific estimates of influenza vaccine effectiveness (IVE) for regulatory and public
Externí odkaz:
https://doaj.org/article/75fb3f72a3704f36bf12c2869d3a6c12
Autor:
Salvador Domènech-Montoliu, Joan Puig-Barberà, Gema Badenes-Marques, María Gil-Fortuño, Alejandro Orrico-Sánchez, María Rosario Pac-Sa, Oscar Perez-Olaso, Diego Sala-Trull, Manuel Sánchez-Urbano, Alberto Arnedo-Pena
Publikováno v:
Vaccines, Vol 11, Iss 10, p 1590 (2023)
Background: In March 2020, a COVID-19 outbreak linked to mass gathering dinners at the Falles Festival in Borriana, Spain, resulted in an estimated attack rate of 42.6% among attendees. Methods: In June 2022, we conducted a cross-sectional follow-up
Externí odkaz:
https://doaj.org/article/f0513b5f81624f4298a9743b27daffaf